CGRP, a vasodilator neuropeptide that stimulates neuromuscular transmission and EC coupling

Current Vascular Pharmacology

Volumn 8, Issue 3, 2010, Pages 394-403

  Vega, Ana Victoria ^a   Avila, Guillermo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Calcitonin gene related peptide; Calcium channels; Central core disease; Dihydropyridine receptor; Excitation contraction coupling; Intracellular calcium; Neuromuscular junction; Ryanodine receptor

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; CAFFEINE; CALCITONIN GENE RELATED PEPTIDE; CYCLIC AMP; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; RYANODINE RECEPTOR; SILDENAFIL; VOLTAGE GATED CALCIUM CHANNEL;

ARTICLE; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CENTRAL CORE DISEASE; DIABETES MELLITUS; EXCITATION CONTRACTION COUPLING; GENE MUTATION; HEART OUTPUT; HUMAN; MEMBRANE DEPOLARIZATION; MICROFLUOROMETRY; MIGRAINE; NEUROMUSCULAR TRANSMISSION; PATCH CLAMP; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SARCOLEMMA; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SMOOTH MUSCLE RELAXATION; VASCULAR RESISTANCE; VASODILATATION; WHOLE CELL;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; EXCITATION CONTRACTION COUPLING; HUMANS; MUSCLE, SKELETAL; NEUROMUSCULAR JUNCTION; SYNAPTIC TRANSMISSION; VASODILATION;

EID: 77952933457     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016110791112287     Document Type: Article

References (135)

1. Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 2004; 84: 903-34.
2. Edvinsson L. Novel migraine therapy with calcitonin gene- regulated peptide receptor antagonists. Expert Opin Ther Targets 2007; 11: 1179-88.
3. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982; 298: 240-4.
4. Amara SG, Arriza JL, Leff SE, Swanson LW, Evans RM, Rosenfeld MG. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 1985; 229: 1094-7.
5. Steenburgh PH, Hoppener JW, Zandberg J, Lips CJ, Jansz HS. A second human calcitonin/CGRP gene. FEBS Lett 1985; 183: 403-7.
6. Pin SS, Bahr BA. Protein kinase C is a common component of CGRP receptor desensitization induced by distinct agonists. Eur J Pharmacol 2008; 587: 8-15.
7. Sakaguchi M, Inaishi Y, Kashihara Y, Kuno M. Release of calcitonin gene-related peptide from nerve terminals in rat skeletal muscle. J Physiol 1991; 434: 257-70.
8. Van Rossum D, Hanisch UK, Quirion R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 1997; 21: 649-78.
9. Mulderry PK, Ghatei MA, Spokes RA, et al. Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience 1988; 25: 195-205.
10. Petermann JB, Born W, Chang JY, Fischer JA. Identification in the human central nervous system, pituitary, and thyroid of a novel calcitonin gene-related peptide, and partial amino acid sequence in the spinal cord. J Biol Chem 1987; 262: 542-5.
11. Alexander SPH, Mathie A, Peters JA. Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 2008; 153(Suppl. 2): 1S-209S.
12. Poyner DR, Sexton PM, Marshall I, et al. International union of pharmacology. XXXII. The Mammalian Calcitonin gene-related peptides, Adrenomedullin, Amylin, and Calcitonin receptors. Pharmacol Rev 2002; 54: 233-46.
13. Sexton PM, Morfis M, Tilakaratne N, et al. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs. Ann NY Acad Sci 2006; 1070: 90-104.
14. McLatchie LM, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393: 333-9.
15. Christopoulos G, Perry KJ, Morfis M, et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 1999; 56: 235-42.
16. Kuwasako K, Shimekake Y, Masuda M, et al. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J Biol Chem 2000; 275: 29602-9.
17. Cottrell GS, Padilla B, Pikios S, et al. Post-endocytic sorting of calcitonin receptor-like receptor and receptor activity-modifying protein 1. J Biol Chem 2007; 282: 12260-71.
18. Dennis T, Fournier A, St Pierre S, Quirion R. Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther 1989; 251: 718-25.
19. Juaneda C, Dumont Y, Quirion R. The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol Sci 2000; 21: 432-8.
20. Hay DL, Poyner DR, Quirion R. International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor. Pharmacol Rev 2008; 60: 143-5.
21. Aiyar N, Rand K, Elshourbagy NA, et al. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 1996; 271: 11325-9.
22. Hay DL. What makes a CGRP2 receptor? Clin Exp Pharmacol Physiol 2007; 34: 963-71.
23. Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 2000; 275: 31438-43.
24. Prado MA, Evans-Bain B, Dickerson IM. Receptor component protein (RCP): a member of a multi-protein complex required for G-protein-coupled signal transduction. Biochem Soc Trans 2002; 30: 460-4.
25. Conner AC, Simms J, Barwell J, Wheatley M, Poyner DR. Ligand binding and activation of the CGRP receptor. Biochem Soc Trans 2007; 35: 729-32.
26. Fontaine B, Klarsfeld A, Hökfelt T, Changeux JP. Calcitonin gene-related peptide, a peptide present in spinal cord motoneurons, increases the number of acetylcholine receptors in primary cultures of chick embryo myotubes. Neurosci Lett 1986; 71: 59-65.
27. Fontaine B, Klarsfeld A, Changeux JP. Calcitonin gene-related peptide and muscle activity regulate acetylcholine receptor alphasubunit mRNA levels by distinct intracellular pathways. Cell Biol 1987;105: 1337-42.
28. da Costa VL Jr, Lapa AJ, Godinho RO. Short- and long-term influences of calcitonin gene-related peptide on the synthesis of acetylcholinesterase in mammalian myotubes. Br J Pharmacol 2001; 133: 229-36.
29. Laufer R, Changeux JP. Calcitonin gene-related peptide and cyclic AMP stimulate phosphoinositide turnover in skeletal muscle cells. Interaction between two second messenger systems. J Biol Chem 1989; 264: 2683-89.
30. Aiyar N, Disa J, Stadel JM, Lysko PG. Calcitonin gene-related peptide receptor independently stimulates 3',5'-cyclic adenosine monophosphate and Ca2+ signaling pathways. Mol Cell Biochem 1999; 197: 179-85.
31. Drissi H, Lasmoles F, Le Mellay V, Marie PJ, Lieberherr M. Activation of phospholipase C-beta1 via Galphaq/11 during calcium mobilization by calcitonin gene-related peptide. J Biol Chem 1998; 273: 20168-74.
32. Hilairet S, Bélanger C, Bertrand J, Laperrière A, Foord SM, Bouvier M. Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin. J Biol Chem 2001; 276: 42182-90.
33. Kuwasako K, Shimekake Y, Masuda M, et al. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J Biol Chem 2000; 275: 29602-9.
34. Laufer R, Changeux JP. Calcitonin gene-related peptide elevates cyclic AMP levels in chick skeletal muscle: possible neurotrophic role for a coexisting neuronal messenger. EMBO J 1987; 6: 901-6.
35. Fanciullacci M, Alessandri M, Figini M, Geppetti P, Michelacci S. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 1995; 60: 119-23.
36. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990; 28: 183-87.
37. Goadsby PJ, Edvinsson L. Neuropeptide changes in a case of chronic paroxysmal hemicrania. Evidence for trigeminoparasympathetic activation. Cephalalgia 1996; 16:448-50.
38. Alessandri M, Massanti L, Geppetti P, Bellucci G, Cipriani M, Fanciullacci M. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache. Cephalgia 2006; 26: 1287-93.
39. Doods H, Arndt K, Rudolf K, Just S. CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci 2007; 28: 580-7.
40. Stevenson JC, MacDonald DW, Warren RC, Booker MW, Whitehead MI. Increased concentration of circulating calcitonin gene related peptide during normal human pregnancy. Br Med J 1986; 293: 1329-30.
41. Halhali A, Wimalawansa SJ, Berentsen V, Avila E, Thota CS, Larrea F. Calcitonin gene- and parathyroid hormone-related peptides in preeclampsia: effects of magnesium sulfate. Obstet Gynecol 2001; 97: 893-7.
42. Joyce CD, Fiscus RR, Wang X, Dries DJ, Morris RC, Prinz RA. Calcitonin gene-related peptide levels are elevated in patients with sepsis. Surgery 1990; 108: 1097-101.
43. Deng PY, Li YJ. Calcitonin gene-related peptide and hypertension. Peptides 2005; 26: 1676-85.
44. Dong YL, Green KE, Vegiragu S, et al. Evidence for decreased calcitonin gene-related peptide (CGRP) receptors and compromised responsiveness to CGRP of fetoplacental vessels in preeclamptic pregnancies. J Clin Endocrinol Metab 2005; 90: 2336-43.
45. Portaluppi F, Trasforini G, Margutti A, et al. Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J Hypertens 1992; 10: 1227-34.
46. Márquez-Rodas I, Longo F, Rothlin RP, Balfagón G. Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension. J Physiol Biochem 2006; 62: 45-56.
47. Gray DW, Marshall I. Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J Pharmacol 1992; 107: 691-6.
48. Wisskirchen FM, Burt RP, Marshall I. Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vasdeferens. Br J Pharmacol 1998; 123: 1673-83.
49. Chan SL, Fiscus RR. Vasorelaxations induced by calcitonin gene-related peptide, vasoactive intestinal peptide, and acetylcholine in aortic rings of endothelial and inducible nitric oxide synthaseknockout mice. J Cardiovasc Pharmacol 2003; 41: 434-43.
50. Stief CG, Wetterauer U, Schaebsdau FH, Jonas U. Calcitonin-gene-related peptide: a possible role in human penile erection and its therapeutic application in impotent patients. J Urol 1991; 146: 1010-4.
51. Stief CG, Benard F, Bosch R, et al. Calcitonin gene-related peptide: possibly neurotransmitter contributes to penile erection in monkeys. Urology 1993; 41: 397-401.
52. Stief CG, Benard F, Bosch RJ, Aboseif SR, Lue TF, Tanagho EA. A possible role for calcitonin-gene-related peptide in the regulation of the smooth muscle tone of the bladder and penis. J Urol 1990; 143: 392-7.
53. Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJ. Nitric oxide and atherosclerosis: an update. Nitric Oxide 2006; 15: 265-79.
54. Li J, Vause CV, Durham PL. Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 2008; 1196: 22-32.
55. Nakata S, Tsutsui M, Shimokawa H, et al. Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway. Arterioscler Thromb Vasc Biol 2007; 27: 92-8.
56. Liberopoulos EN, Mikhailidis DP. Could statins be useful in the treatment of patients with migraine? Headache 2006; 46: 672-5.
57. Medeiros FL, Medeiros PL, Valença MM, Dodick D. Simvastatin for migraine prevention. Headache 2007; 47: 855-6.
58. Bucelli RC, Gonsiorek EA, Kim WY, et al. Statins decrease expression of the proinflammatory neuropeptides calcitonin gene-related peptide and substance P in sensory neurons. J Pharmacol Exp Ther 2008; 324: 1172-80.
59. Huebner AK, Keller J, Catala-Lehnen P, et al. The role of calcitonin and alpha-calcitonin gene-related peptide in bone formation. Arch Biochem Biophys 2008; 473: 210-7.
60. Herbert, MK, Holzer P. Interleukin-1 ß enhances capsaicin induced neurogenic vasodilatation in the rat skin. Br J Pharmacol 1994; 111: 681-6.
61. Li WJ, Wang TK. Calcitonin gene-related peptide inhibits interleu- kin-1ß-induced interleukin-8 secretion in human type II alveolar epithelial cells. Acta Pharmacol Sin 2006; 27: 1340-5.
62. Xing L, Guo J, Wang X. Induction and expression of beta- calcitonin gene-related peptide in rat T lymphocytes and its significance. J Immunol 2000; 165: 4359-66.
63. Sakagami Y, Girasole G, Yu XO, Boswell HS, Manolagas SC. Stimulation of interleukin-6 production by either calcitonin gene-related peptide or parathyroid hormone in two phenotypically distinct bone marrow-derived murine stromal cell lines. J Bone Miner Res 1993; 8: 811-16.
64. Sakuta H, Inaba K, Muramatsu S. Calcitonin gene-related peptide enhances cytokine-induced IL-6 production by fibroblasts. Cell Immunol 1995; 165: 20-25.
65. Umeda Y, Takamiya M, Yoshizaki H, Arisawa M. Inhibition of mitogen-stimulated T lymphocyte proliferation by calcitonin gene-related peptide. Biochem Biophys Res Commun 1988; 154: 227-35.
66. Liu C, Chen X, Jin Y, et al. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Dermatol 2007; 32: 650-3.
67. Schlomer JJ, Storey BB, Ciornei RT, McGillis JP. Calcitonin gene-related peptide inhibits early B cell development in vivo. J Leukoc Biol 2007; 81: 802-8.
68. Young A. Inhibition of insulin secretion. Adv Pharmacol 2005; 52: 173-92.
69. Young A. Historical background. Adv Pharmacol 2005; 52: 1-18.
70. Ahrén B, Sundler F. Localization of calcitonin gene-related peptide and islet amyloid polypeptide in the rat and mouse pancreas. Cell Tissue Res 1992; 269: 315-22.
71. Pettersson M, Ahrén B, Böttcher G, Sundler F. Calcitonin gene-related peptide: occurrence in pancreatic islets in the mouse and the rat and inhibition of insulin secretion in the mouse. Endocrinology 1986; 119: 865-9.
72. Ahrén B, Mårtensson H, Nobin A. Effects of calcitonin gene-related peptide (CGRP) on islet hormone secretion in the pig. Diabetologia 1987; 30: 354-9.
73. Kogire M, Ishizuka J, Thompson JC, Greeley GH Jr. Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas. Pancreas 1991; 6: 459-63.
74. Gram DX, Hansen AJ, Wilken M, et al. Plasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats. Eur J Endocrinol 2005; 153: 963-9.
75. Gram DX, Ahrén B, Nagy I, et al. Capsaicin-sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes. Eur J Neurosci 2007; 25: 213-23.
76. Danaher RN, Loomes KM, Leonard BL, et al. Evidence that alpha-calcitonin gene-related peptide is a neurohormone that controls systemic lipid availability and utilization. Endocrinology 2008; 149: 154-60.
77. Sala C, Andreose JS, Fumagalli G, Lømo T. Calcitonin gene-related peptide: possible role in formation and maintenance of neuromuscular junctions. J Neurosci 1995; 15: 520-8.
78. Rodrigo J, Polak JM, Terenghi G, et al. Calcitonin gene-related peptide (CGRP)-immunoreactive sensory and motor nerves of the mammalian palate. Histochemistry 1985; 82: 67-74.
79. Chantry A, Leighton B, Day AJ. Cross-reactivity of amylin with calcitonin-gene-related peptide binding sites in rat liver and skeletal muscle membranes. Biochem J 1991; 277: 139-43.
80. Uchida S, Yamamoto H, Iio S, et al. Release of calcitonin gene-related peptide-like immunoreactive substance from neuromuscular junction by nerve excitation and its action on striated muscle. J Neurochem 1990; 54: 1000-3.
81. Fernandez HL, Chen M, Nadelhaft I, Durr JA. Calcitonin gene-related peptides: their binding sites and receptor accessory proteins in adult mammalian skeletal muscles. Neuroscience 2003; 119: 335-45.
82. Rossi SG, Dickerson IM, Rotundo RL. Localization of the calcitonin gene-related peptide receptor complex at the vertebrate neu romuscular junction and its role in regulating acetylcholinesterase expression. J Biol Chem 2003; 278: 24994-5000.
83. Matteoli M, Balbi S, Sala C, et al. Developmentally regulated expression of calcitonin gene-related peptide at mammalian neuromuscular junction. J Mol Neurosci 1990; 2: 175-84.
84. Schütz B, Mauer D, Salmon AM, Changeux JP, Zimmer A. Analysis of the cellular expression pattern of ß-CGRP in alpha-CGRPdeficient mice. J Comp Neurol 2004; 476: 32-43.
85. Homonko DA, Theriault E. Downhill running preferentially increases CGRP in fast glycolytic muscle fibers. J Appl Physiol 2000; 89: 1928-36.
86. Jonhagen S, Ackermann P, Saartok T, Renstrom PA. Calcitonin gene related peptide and neuropeptide Y in skeletal muscle after eccentric exercise: a microdialysis study. Br J Sports Med 2006; 40: 264-7.
87. Tarabal O, Calderó J, Ribera J, et al. Regulation of motoneuronal calcitonin gene-related peptide (CGRP) during axonal growth and neuromuscular synaptic plasticity induced by botulinum toxin in rats. Eur J Neurosci 1996; 8: 829-36.
88. Tarabal O, Calderó J, Esquerda JE. Intramuscular nerve sprouting induced by CNTF is associated with increases in CGRP content in mouse motor nerve terminals. Neurosci Lett 1996; 219: 60-4.
89. Zheng LF, Wang R, Xu YZ, Yi XN, Zhang JW, Zeng ZC. Calcitonin gene-related peptide dynamics in rat dorsal root ganglia and spinal cord following different sciatic nerve injuries. Brain Res 2008; 1187: 20-32.
90. Sarasa M, Terrado J, Mengod G, Climent S, Muniesa P, Palacios JM. Differential expression of alpha-CGRP and beta-CGRP genes within hypoglossal motoneurons in response to axotomy. Brain Res Mol Brain Res 1996; 35: 269-77.
91. Ramer MS, Bradbury EJ, Michael GJ, Lever IJ, McMahon SB. Glial cell line-derived neurotrophic factor increases calcitonin gene-related peptide immunoreactivity in sensory and motoneurons in vivo. Eur J Neurosci 2003; 18: 2713-21.
92. Piehl F, Hammarberg H, Hökfelt T, Cullheim S. Regulatory effects of trophic factors on expression and distribution of CGRP and GAP-43 in rat motoneurons. J Neurosci Res 1998; 51: 1-14.
93. Piehl F, Ji RR, Cullheim S, Hökfelt T, Lindholm D, Hughes RA. Fibroblast growth factors regulate calcitonin gene-related peptide mRNA expression in rat motoneurons after lesion and in culture. Eur J Neurosci 1995; 7: 1739-50.
94. Buffelli M, Pasino E, Cangiano A. In vivo acetylcholine receptor expression induced by calcitonin gene-related peptide in rat soleus muscle. Neuroscience 2001; 104: 561-7.
95. Fernandez HL, Hodges-Savola CA. Axoplasmic transport of calcitonin gene-related peptide in rat peripheral nerve as a function of age. Neurochem Res 1994; 19: 1369-77.
96. Noble BS, McMillan DN, Maltin CA. Calcitonin gene related peptide stimulates differentiation of neonatal rat myogenic cultures. Growth Regul 1993; 3: 245-8.
97. Okazaki S, Kawai H, Arii Y, Yamaguchi H, Saito S. Effects of calcitonin gene-related peptide and interleukin 6 on myoblast differentiation. Cell Prolif 1996; 29: 173-82.
98. Mulle C, Benoit P, Pinset C, Roa M, Changeux JP. Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells. Proc Natl Acad Sci USA 1988; 85: 5728-32.
99. Lu B, Fu WM, Greengard P, Poo MM. Calcitonin gene-related peptide potentiates synaptic responses at developing neuromuscular junction. Nature 1993; 363: 76-9.
100. New HV, Mudge AW. Calcitonin gene-related peptide regulates muscle acetylcholine receptor synthesis. Nature 1986; 323: 809-11.
101. Boudreau-Larivière C, Jasmin BJ. Calcitonin gene-related peptide decreases expression of acetylcholinesterase in mammalian myotubes. FEBS Lett 1999; 444: 22-6.
102. Takami K, Kawai Y, Uchida S, et al. Effect of calcitonin gene-related peptide on contraction of striated muscle in the mouse. Neurosci Lett 1985; 60: 227-30.
103. Takami K, Hashimoto K, Uchida S, Tohyama M, Yoshida H. Effect of calcitonin gene-related peptide on the cyclic AMP level of isolated mouse diaphragm. Jpn J Pharmacol 1986; 42: 345-50.
104. Andersen SL, Clausen T. Calcitonin gene-related peptide stimulates active Na(+)-K+ transport in rat soleus muscle. Am J Physiol 1993; 264: C419-29.
105. Avila G, Aguilar CI, Ramos-Mondragón R. Sustained CGRP1 receptor stimulation modulates development of EC coupling by cAMP/PKA signalling pathway in mouse skeletal myotubes. J Physiol 2007; 584: 47-57.
106. Parker MH, Seale P, Rudnicki MA. Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat Rev Genet 2003; 4: 497-507.
107. Ray A, Kyselovic J, Leddy JJ, Wigle JT, Jasmin BJ, Tuana BS. Regulation of dihydropyridine and ryanodine receptor gene expression in skeletal muscle. Role of nerve, protein kinase C, and cAMP pathways. J Biol Chem 1995; 270: 25837-44.
108. Mejia-Luna L, Avila G. Ca2+ channel regulation by transforming growth factor-beta 1 and bone morphogenetic protein-2 in developing mice myotubes. J Physiol 2004; 559: 41-54.
109. Marty I, Robert M, Villaz M, et al. Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of skeletal muscle. Proc Natl Acad Sci U S A 1994; 91: 2270-4.
110. Armstrong CM, Bezanilla FM, Horowicz P. Twitches in the presence of ethylene glycol bis(-aminoethyl ether)-N,N'-tetracetic acid. Biochim Biophys Acta 1972; 267: 605-8.
111. Melzer W, Herrmann-Frank A, Lüttgau HC. The role of Ca2+ ions in excitation-contraction coupling of skeletal muscle fibres. Biochim Biophys Acta 1995; 1241: 59-116.
112. Dirksen RT. Bi-directional coupling between dihydropyridine receptors and ryanodine receptors. Front Biosci 2002; 7: d659-70.
113. Flockerzi V, Oeken HJ, Hofmann F, Pelzer D, Cavalié A, Trautwein W. Purified dihydropyridine-binding site from skeletal muscle t-tubules is a functional calcium channel. Nature 1986; 323: 66-8.
114. Hain J, Nath S, Mayrleitner M, Fleischer S, Schindler H. Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from skeletal muscle. Biophys J 1994; 67: 1823-33.
115. Lai Y, Seagar MJ, Takahashi M, Catterall WA. Cyclic AMPdependent phosphorylation of two size forms of alpha 1 subunits of L-type calcium channels in rat skeletal muscle cells. J Biol Chem 1990; 265: 20839-48.
116. García J, Gamboa-Aldeco R, Stefani E. Charge movement and calcium currents in skeletal muscle fibers are enhanced by GTP gamma S. Pflugers Arch 1990; 417: 114-6.
117. Sculptoreanu A, Rotman E, Takahashi M, Scheuer T, Catterall WA. Voltage-dependent potentiation of the activity of cardiac Ltype calcium channel alpha 1 subunits due to phosphorylation by cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1993; 90: 10135-9.
118. Reiken S, Lacampagne A, Zhou H, et al. PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure. J Cell Biol 2003; 160: 919-28.
119. Fabiato A, Fabiato F. Cyclic AMP-induced enhancement of calcium accumulation by the sarcoplasmic reticulum with no modification of the sensitivity of the myofilaments to calcium in skinned fibres from a yeast skeletal muscle. Biochim Biophys Acta 1978; 539: 253-60.
120. Gonzalez-Serratos H, Hill L, Valle-Aguilera R. Effects of catecholamines and cyclic amp on excitation-contraction coupling in isolated skeletal muscle fibres of the frog. J Physiol 1981; 315: 267-82.
121. Blazev R, Hussain M, Bakker AJ, Head SI, Lamb GD. Effects of the PKA inhibitor H-89 on excitation-contraction coupling in skinned and intact skeletal muscle fibres. J Muscle Res Cell Motil 2001; 22: 277-86.
122. Rudolf R, Magalhaes PJ, Pozzan T. Direct in vivo monitoring of sarcoplasmic reticulum Ca2+ and cytosolic cAMP dynamics in mouse skeletal muscle. J Cell Biol 2006; 173: 187-93.
123. Simmerman HK, Jones LR. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 1998; 78: 921-47.
124. Stenoien DL, Knyushko TV, Londono MP, et al. Cellular trafficking of phospholamban and formation of functional sarcoplasmic reticulum during myocyte differentiation. Am J Physiol Cell Physiol 2007; 292: C2084-94.
125. Buck ED, Nguyen HT, Pessah IN, Allen PD. Dyspedic mouse skeletal muscle expresses major elements of the triadic junction but lacks detectable ryanodine receptor protein and function. J Biol Chem 1997; 272: 7360-7.
126. Avila G, Dirksen RT. Functional impact of the ryanodine receptor on the skeletal muscle L-type Ca(2+) channel. J Gen Physiol 2000; 115: 467-80.
127. Avila G, O'Connell KM, Groom LA, Dirksen RT. Ca2+ release through ryanodine receptors regulates skeletal muscle L-type Ca2+ channel expression. J Biol Chem 2001; 276: 17732-8.
128. Zvaritch E, Depreux F, Kraeva N, et al. An Ryr1I4895T mutation abolishes Ca2+ release channel function and delays development in homozygous offspring of a mutant mouse line. Proc Natl Acad Sci USA 2007; 104: 18537-42.
129. Avila G. Intracellular Ca2+ dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involved. Cell Calcium 2005; 37: 121-7.
130. Jungbluth H. Central core disease. Orphanet J Rare Dis 2007; 2: 25.
131. Tong J, McCarthy TV, MacLennan DH. Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels. J Biol Chem 1999; 274: 693-702.
132. Avila G, Dirksen RT. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor. J Gen Physiol 2001; 118: 277-90.
133. Avila G, O'Brien JJ, Dirksen RT. Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor. Proc Natl Acad Sci USA 2001; 98: 4215-20.
134. Avila G, O'Connell KM, Dirksen RT. The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitationcontraction uncoupling in central core disease. J Gen Physiol 2003; 121: 277-86.
135. Dirksen RT, Avila G. Altered ryanodine receptor function in central core disease: leaky or uncoupled Ca(2+) release channels? Trends Cardiovasc Med 2002; 12: 189-97.